Revvity CEO to Outline Strategic Priorities at Two Key Healthcare Conferences

  • Revvity CEO Prahlad Singh to present at Jefferies Global Healthcare Conference on November 17, 2026
  • Singh will also speak at Evercore Healthcare Conference on December 2, 2026
  • Presentations will cover company updates and strategic priorities
  • Live webcasts available; replays posted for 30 days post-event

Revvity's back-to-back conference appearances come as the healthcare technology sector faces increasing pressure to demonstrate ROI on complex diagnostic solutions. With $2.9 billion in 2025 revenue and operations in 160 countries, the company's strategic messaging will be closely watched by investors assessing its ability to maintain growth momentum. The presentations may reveal how Revvity plans to leverage its scale in an increasingly fragmented market for health science solutions.

Strategic Clarity
How Revvity will articulate its path to growth amid competitive healthcare tech landscape
Market Positioning
Whether Revvity can differentiate itself in translational multi-omics and biomarker identification
Execution Pace
The speed at which Revvity translates strategic priorities into revenue impact